Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fozivudine Dose Confirmation in HIV-1
NCT01714414Phase 2Completed
- Start
- Dec 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of fozivudine tidoxil in human immunodeficiency virus type 1 infection (HIV-1). Started Dec 2012; status: completed.
02
Drugs
fozivudine tidoxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01714414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714414.